1. Biopharmaceutical and clinical pharmacokinetic profile of bromazepam

   • S. A. Kaplan
   • M. L. Jack
   • S. Cotler

   OriginalPaper 17 July 2015 Pages: 1 - 16

2. Contribution of the liver to overall elimination of propranolol

   • Charles F. George
   • Michael L'E Orme
   • Colin T. Dollery

   OriginalPaper 17 July 2015 Pages: 17 - 27

3. Differential pulse polarographic assay procedure andin vitro biopharmaceutical properties of dipotassium clorazepate

   • C. W. Abruzzo
   • M. A. Brooks
   • S. A. Kaplan

   OriginalPaper 17 July 2015 Pages: 29 - 41

4. Inappropriate use of the law of corresponding areas to calculate the time course of absorption for multicompartmental systems

   • Renato L. Galeazzi
   • Leslie Z. Benet

   OriginalPaper 17 July 2015 Pages: 43 - 56

5. Ergot alkaloids: Hepatic distribution and estimation of absorption by measurement of total radioactivity in bile and urine

   • Fritz Nimmerfall
   • Joachim Rosenthaler

   OriginalPaper 17 July 2015 Pages: 57 - 66

6. Dose-effect curves and relative biophasic drug levels: Elucidation of these concepts and the illustration of their use for the determination of bioavailability, rate of absorption, and time course of pharmacological response

   • William A. Weigand
   • Ashok K. Jhawar

   OriginalPaper 17 July 2015 Pages: 67 - 80